Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Chembio receives grant to develop PoC Zika diagnostics

Feb. 22, 2016

FDA approves Harvoni for additional chronic HCV indications

Feb. 19, 2016

FDA accepts for review sNDA for Teflaro in pediatric population

Feb. 19, 2016

Genedrive HCV test completes successful external assessment and gets ready for clinical testing

Feb. 19, 2016

Inovio Pharmaceutical's DNA Zika virus vaccine induces robust immune responses in vivo

Feb. 19, 2016

Interim data suggest potential for RG-101 as backbone therapy for HCV

Feb. 18, 2016

GVN launches Zika Task Force to combat the global Zika outbreak

Feb. 18, 2016

Biotron to test its antiviral compounds for activity against Zika virus

Feb. 18, 2016

RB launches a Zika Relief Package in response to the global outbreak

Feb. 18, 2016

Zepatier available in U.S.

Feb. 17, 2016

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...